Sultan َQaboos University Hospital

Muscat 123

1 studies enrolling now · 9 studies all time

What they study most

Hemophilia A, Hemophilia B, Sickle Cell Disease, Vaso-occlusive Crisis, Vaso-occlusive Pain Episode in Sickle Cell Disease

Studies at this site

• Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors — Recruiting now
• Study to Evaluate the Effect of GBT440 on TCD in Pediatrics With Sickle Cell Disease — Stopped early
• A Study to Evaluate the Long-term Safety of Inclacumab Administered to Participants With Sickle Cell Disease — Stopped early
• A Study to Assess the Safety and Efficacy of Inclacumab in Participants With Sickle Cell Disease Experiencing Vaso-occlusive Crises — Completed
• Study to Assess the Effect of Long-term Treatment With Voxelotor in Participants Who Have Completed Treatment in Study GBT440-031 — Stopped early
• Study of the Efficacy and Safety PF-06741086 in Adult and Teenage Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B — Completed
• A Study of IMR-687 in Subjects With Sickle Cell Disease — Stopped early
• A Study of a Single Dose of Inclacumab to Reduce Re-admission in Participants With Sickle Cell Disease and Recurrent Vaso-occlusive Crises — Stopped early
• Study Evaluating Prophylaxis Treatment & Characterizing Efficacy, Safety, & PK Of B-Domain Deleted Recombinant FVIII — Completed